NHS In England Bans Puberty Blockers For Kids

England’s National Health Services (NHS) announced this week that children would no longer be prescribed puberty blockers at gender identity clinics.

The decision comes after the NHS commissioned the National Institute for Health and Care Excellence (NICE) to review published evidence on gonadotropin-releasing hormone analogues (GnRHa), better known as puberty blockers.

“NHS England has carefully considered the evidence review conducted by NICE and has identified and reviewed any further published evidence available to date,” said an NHS document. “We have concluded that there is not enough evidence to support the safety or clinical effectiveness of PSH to make the treatment routinely available.”

GnRHa is a class of drug that suppresses hormones in adolescents by continually stimulating the pituitary gland. Research has shown that these puberty blockers can be linked to poor mental health among supposed “transgender kids.”

According to Fox News, U.K. researchers determined that “one-third of the youth with gender dysphoria (GD) experienced a decline in mental health after taking triptorelin.”

The initial investigation was launched after a significant increase in the number of children who were being referred to NHS-run gender identity clinics in England.

According to the Daily Mail, “The number went from 250 children in 2012 to more than 5,000 in 2022 as the transgender movement gained steam as a social trend and experts warned that it was having a contagion effect.”

Currently, fewer than 100 children are on puberty blockers in the U.K., and those kids will have continued access to the drugs through the NHS. Any kids, starting today, will not have access to the dangerous drugs.

As it stands, puberty blockers will still be available to children in limited ways such as clinical trials and through some private practices. Former Prime Minister Liz Truss’s “Health and Equality Acts” bill also includes a ban on all puberty blockers whether from a public or private institution.

“I welcome NHS England’s decision to end the routine prescription of puberty blockers to children for gender dysphoria. I urge the Government to back my Bill on Friday which will reinforce this in law and also prevent these drugs being supplied privately,” Truss said.